Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022

by NASDAQ Market News December 7, 2021

NASDAQ Market News
Click here to email author

Enlivex Receives Regulatory Authorization to Expand its Phase II Sepsis Trial into Greece

Prometheus Biosciences Reports Positive Topline Phase 1 Data on Lead Therapeutic Candidate PRA023; Expands Indications to Include Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

Ads